Program Description: 

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

Target audience: 
Physician
Physician (fellow/resident)
Psychologist
Social Worker
Physician Assistant
Nurse
Nurse Practitioner
AP/NP
Allied Health Care Professionals
Learning objectives: 
  1. Understand the correct way to take a history in a patient presenting with a first seizure
  2. Explain the alternative diagnoses in a patient presenting with “episodes”
  3. Understand the availability of tools for proper diagnosis of epilepsy patients
Faculty & credentials: 

Presenter(s)

Jacqueline French, MD
Professor of Neurology
NYU Langone Epilepsy Center
Chief Medical/Innovation Officer of the Epilepsy Foundation
Director of the Epilepsy Study Consortium

All persons in control of content have NO relevant financial relationships to disclosure except:

In accordance with the ACCME® standard for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

 

Name

Company

Role

Jacqueline French, MD

Epilepsy Foundation

 

Chief Medical/Innovation Officer

Jacqueline French, MD

Aeonian/Aeovian, Anavex, Arvelle Therapeutics, Inc., Athenen Therapeutics/Carnot Pharma, Axovant, Biogen, BioXcel Therapeutics, Blackfynn, Cerebral Therapeutics, Cerevel, Crossject, CuroNZ, Eisai, Encoded Therapeutics, Engage Therapeutics, Epiminder, Epitel, Fortress Biotech, Greenwich Biosciences, GW Pharma, Ionis, Janssen Pharmaceutica, Knopp Biosciences, Lundbeck, Marinus, Merck, NeuCyte, Inc., Neurocrine, Otsuka Pharmaceutical Development, Ovid Therapeutics Inc., Passage Bio, Pfizer, Praxis, Redpin, Sage, SK Life Sciences, Stoke, Sunovion, Supernus, Takeda, UCB Inc., Xenon, Xeris, Zogenix

Scientific Advisory Board

Jacqueline French, MD

Biogen, Cavion, Eisai, Engage, GW Pharma, Lundbeck, Neurelis, Ovid, Pfizer, SK Life Sciences, Sunovion, UCB, Xenon and Zogenix Epilepsy Research Foundation, Epilepsy Study Consortium, and NINDS

Research Grant

Jacqueline French, MD

Lancet Neurology and Neurology Today

Editorial Board

Contact

Name: 
Laura Kurth
Phone number: 
+1 (414) 955-0650
Session date: 
Friday, September 25, 2020 - 8:00am to 9:00am
Location: 
Webex only
WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.